Literature DB >> 21436586

Mouse and human neutrophils induce anaphylaxis.

Friederike Jönsson1, David A Mancardi, Yoshihiro Kita, Hajime Karasuyama, Bruno Iannascoli, Nico Van Rooijen, Takao Shimizu, Marc Daëron, Pierre Bruhns.   

Abstract

Anaphylaxis is a life-threatening hyperacute immediate hypersensitivity reaction. Classically, it depends on IgE, FcεRI, mast cells, and histamine. However, anaphylaxis can also be induced by IgG antibodies, and an IgG1-induced passive type of systemic anaphylaxis has been reported to depend on basophils. In addition, it was found that neither mast cells nor basophils were required in mouse models of active systemic anaphylaxis. Therefore, we investigated what antibodies, receptors, and cells are involved in active systemic anaphylaxis in mice. We found that IgG antibodies, FcγRIIIA and FcγRIV, platelet-activating factor, neutrophils, and, to a lesser extent, basophils were involved. Neutrophil activation could be monitored in vivo during anaphylaxis. Neutrophil depletion inhibited active, and also passive, systemic anaphylaxis. Importantly, mouse and human neutrophils each restored anaphylaxis in anaphylaxis-resistant mice, demonstrating that neutrophils are sufficient to induce anaphylaxis in mice and suggesting that neutrophils can contribute to anaphylaxis in humans. Our results therefore reveal an unexpected role for IgG, IgG receptors, and neutrophils in anaphylaxis in mice. These molecules and cells could be potential new targets for the development of anaphylaxis therapeutics if the same mechanism is responsible for anaphylaxis in humans.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21436586      PMCID: PMC3069785          DOI: 10.1172/JCI45232

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  44 in total

Review 1.  Anaphylaxis in the United States: an investigation into its epidemiology.

Authors:  A I Neugut; A T Ghatak; R L Miller
Journal:  Arch Intern Med       Date:  2001-01-08

2.  Treatment with liposome-encapsulated clodronate as a new strategic approach in the management of immune thrombocytopenic purpura in a mouse model.

Authors:  F Alves-Rosa; C Stanganelli; J Cabrera; N van Rooijen; M S Palermo; M A Isturiz
Journal:  Blood       Date:  2000-10-15       Impact factor: 22.113

3.  Release of platelet-activating factor (PAF) and histamine. II. The cellular origin of human PAF: monocytes, polymorphonuclear neutrophils and basophils.

Authors:  G Camussi; M Aglietta; R Coda; F Bussolino; W Piacibello; C Tetta
Journal:  Immunology       Date:  1981-02       Impact factor: 7.397

4.  Activities of enzymes that metabolize platelet-activating factor (1-Alkyl-2-acetyl-sn-glycero-3-phosphocholine) in neutrophils and eosinophils from humans and the effect of a calcium ionophore.

Authors:  T C Lee; B Malone; S I Wasserman; V Fitzgerald; F Snyder
Journal:  Biochem Biophys Res Commun       Date:  1982-04-29       Impact factor: 3.575

5.  Human neutrophil-derived platelet activating factor.

Authors:  G Z Lotner; J M Lynch; S J Betz; P M Henson
Journal:  J Immunol       Date:  1980-02       Impact factor: 5.422

6.  Human neutrophils express the high-affinity receptor for immunoglobulin E (Fc epsilon RI): role in asthma.

Authors:  A S Gounni; B Lamkhioued; L Koussih; C Ra; P M Renzi; Q Hamid
Journal:  FASEB J       Date:  2001-04       Impact factor: 5.191

7.  Pathways of anaphylaxis in the mouse.

Authors:  Richard T Strait; Suzanne C Morris; Mingyan Yang; Xiao-Wu Qu; Fred D Finkelman
Journal:  J Allergy Clin Immunol       Date:  2002-04       Impact factor: 10.793

8.  Cutting Edge: The murine high-affinity IgG receptor FcγRIV is sufficient for autoantibody-induced arthritis.

Authors:  David A Mancardi; Friederike Jönsson; Bruno Iannascoli; Huot Khun; Nico Van Rooijen; Michel Huerre; Marc Daëron; Pierre Bruhns
Journal:  J Immunol       Date:  2011-01-19       Impact factor: 5.422

9.  The control effect of histamine on body temperature and respiratory function in IgE-dependent systemic anaphylaxis.

Authors:  Yoko Makabe-Kobayashi; Yoshio Hori; Tetsuya Adachi; Satsuki Ishigaki-Suzuki; Yoshihiro Kikuchi; Yutaka Kagaya; Kunio Shirato; András Nagy; Azusa Ujike; Toshiyuki Takai; Takehiko Watanabe; Hiroshi Ohtsu
Journal:  J Allergy Clin Immunol       Date:  2002-08       Impact factor: 10.793

10.  Arthritogenic monoclonal antibodies from K/BxN mice.

Authors:  Mariana Maccioni; Gabrielle Zeder-Lutz; Haochu Huang; Claudine Ebel; Philippe Gerber; Josiane Hergueux; Patricia Marchal; Veronique Duchatelle; Claude Degott; Marc van Regenmortel; Christophe Benoist; Diane Mathis
Journal:  J Exp Med       Date:  2002-04-15       Impact factor: 14.307

View more
  94 in total

Review 1.  Deciphering the structure and function of FcεRI/mast cell axis in the regulation of allergy and anaphylaxis: a functional genomics paradigm.

Authors:  Jayapal Manikandan; Narasimhan Kothandaraman; Manoor Prakash Hande; Peter Natesan Pushparaj
Journal:  Cell Mol Life Sci       Date:  2011-12-07       Impact factor: 9.261

Review 2.  Mediators released during human anaphylaxis.

Authors:  Shelley F Stone; Simon G A Brown
Journal:  Curr Allergy Asthma Rep       Date:  2012-02       Impact factor: 4.806

3.  IgA attenuates anaphylaxis and subsequent immune responses in mice: possible application of IgA to vaccines.

Authors:  Kouya Yamaki; Takayuki Nakashima; Kenji Miyatake; Yuki Ishibashi; Ayaka Ito; Ayu Kuranishi; Akihito Taguchi; Ayumi Morioka; Midori Yamamoto; Shin Yoshino
Journal:  Immunol Res       Date:  2014-01       Impact factor: 2.829

Review 4.  The multifaceted functions of neutrophils.

Authors:  Tanya N Mayadas; Xavier Cullere; Clifford A Lowell
Journal:  Annu Rev Pathol       Date:  2013-09-16       Impact factor: 23.472

5.  Delayed clinical and ex vivo response to mammalian meat in patients with IgE to galactose-alpha-1,3-galactose.

Authors:  Scott P Commins; Hayley R James; Whitney Stevens; Shawna L Pochan; Michael H Land; Carol King; Susan Mozzicato; Thomas A E Platts-Mills
Journal:  J Allergy Clin Immunol       Date:  2014-03-20       Impact factor: 10.793

6.  Attenuation of murine allergic airway inflammation with a CXCR1/CXCR2 chemokine receptor inhibitor.

Authors:  Koa Hosoki; Krishna Rajarathnam; Sanjiv Sur
Journal:  Clin Exp Allergy       Date:  2018-10-05       Impact factor: 5.018

7.  Shifting FcγRIIA-ITAM from activation to inhibitory configuration ameliorates arthritis.

Authors:  Sanae Ben Mkaddem; Gilles Hayem; Friederike Jönsson; Elisabetta Rossato; Erwan Boedec; Tarek Boussetta; Jamel El Benna; Pierre Launay; Jean-Michel Goujon; Marc Benhamou; Pierre Bruhns; Renato C Monteiro
Journal:  J Clin Invest       Date:  2014-07-25       Impact factor: 14.808

8.  Repeated PD-1/PD-L1 monoclonal antibody administration induces fatal xenogeneic hypersensitivity reactions in a murine model of breast cancer.

Authors:  Christine Mall; Gail D Sckisel; David A Proia; Annie Mirsoian; Steven K Grossenbacher; Chien-Chun Steven Pai; Mingyi Chen; Arta M Monjazeb; Karen Kelly; Bruce R Blazar; William J Murphy
Journal:  Oncoimmunology       Date:  2015-08-12       Impact factor: 8.110

9.  Allergy: shocking behaviour.

Authors:  Yvonne Bordon
Journal:  Nat Rev Immunol       Date:  2011-05       Impact factor: 53.106

10.  Anaphylaxis caused by repetitive doses of a GITR agonist monoclonal antibody in mice.

Authors:  Judith T Murphy; Andre P Burey; Amy M Beebe; Danling Gu; Leonard G Presta; Taha Merghoub; Jedd D Wolchok
Journal:  Blood       Date:  2014-02-20       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.